1-7 of 7
Maurilio Ponzoni
Close
Sort by
Journal Articles

EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential

Yong Li, Zijun Y. Xu-Monette, Jeremy Abramson, Aliyah R. Sohani, Govind Bhagat, Alexandar Tzankov, Carlo Visco, Shanxiang Zhang, Karen Dybkaer, Zenggang Pan, Min Xu, Wayne Tam, Youli Zu, Eric D. Hsi, Fredrick B. Hagemeister, Heounjeong Go, J. Han van Krieken, Jane N. Winter, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Miguel A. Piris, Yingjun Wang, Mingzhi Zhang, Ken H. Young
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1308–1311.
https://doi.org/10.1182/bloodadvances.2022008550
Published: 2023
Includes: Supplemental data
Journal Articles

Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma

Andrés J. M. Ferreri, Piera Angelillo, Federico Erbella, Chiara Cattaneo, Luisa Verga, Arben Lleshi, Bernardino Allione, Maurilio Ponzoni, Fabio Facchetti, Chiara Pagani, Marco Foppoli, Lorenza Pecciarini, Marianna Sassone, Sara Steffanoni, Elena Flospergher, Giuseppe Rossi, Michele Spina, Alessandro Re
Journal: Blood Advances
Blood Adv (2022) 6 (22): 5811–5820.
https://doi.org/10.1182/bloodadvances.2022007475
Published: 2022
Journal Articles

Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial

Lydia Scarfò, Silvia Ferrari, Anna Maria Frustaci, Monica Tani, Alessia Bari, Eloise Scarano, Maria Colia, Pamela Ranghetti, Piera Angelillo, Paola Ronchi, Maurilio Ponzoni, Andrés J. M. Ferreri, Paolo Ghia
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5356–5359.
https://doi.org/10.1182/bloodadvances.2022007138
Published: 2022
Includes: Supplemental data
Journal Articles

CD4 + T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanism

Matteo Grioni, Arianna Brevi, Elena Cattaneo, Alessandra Rovida, Jessica Bordini, Maria Teresa Sabrina Bertilaccio, Maurilio Ponzoni, Giulia Casorati, Paolo Dellabona, Paolo Ghia, Matteo Bellone, Arianna Calcinotto
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2817–2828.
https://doi.org/10.1182/bloodadvances.2020003795
Published: 2021
Journal Articles

Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial

Clinical Trials & Observations
Andrés J. M. Ferreri, Teresa Calimeri, Maurilio Ponzoni, Flavio Curnis, Gian Marco Conte, Eloise Scarano, Eltjona Rrapaj, Daniela De Lorenzo, Dario Cattaneo, Federico Fallanca, Alessandro Nonis, Marco Foppoli, Paolo Lopedote, Giovanni Citterio, Letterio S. Politi, Marianna Sassone, Piera Angelillo, Elena Guggiari, Sara Steffanoni, Vittoria Tarantino, Fabio Ciceri, Claudio Bordignon, Nicoletta Anzalone, Angelo Corti
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3648–3658.
https://doi.org/10.1182/bloodadvances.2020002270
Published: 2020
Includes: Multimedia, Supplemental data
Journal Articles

A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL

Zijun Y. Xu-Monette, Hongwei Zhang, Feng Zhu, Alexandar Tzankov, Govind Bhagat, Carlo Visco, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, Hua You, Jooryung Huh, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Benjamin M. Parsons, J. Han van Krieken, Miguel A. Piris, Jane N. Winter, Fredrick B. Hagemeister, Babak Shahbaba, Ivan De Dios, Hong Zhang, Yong Li, Bing Xu, Maher Albitar, Ken H. Young
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3391–3404.
https://doi.org/10.1182/bloodadvances.2020001949
Published: 2020
Includes: Supplemental data
Journal Articles

Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum

Clinical Trials & Observations
Andrés J. M. Ferreri, Marianna Sassone, Elisabetta Miserocchi, Silvia Govi, Caterina Cecchetti, Matteo E. Corti, Silvia Mappa, Luca Arcaini, Francesco Zaja, Giuseppe Todeschini, Donato Mannina, Teresa Calimeri, Salvatore Perrone, Maurilio Ponzoni, Giulio Modorati
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1013–1019.
https://doi.org/10.1182/bloodadvances.2020001459
Published: 2020